STOCK TITAN

Khiron Life Sciences Corp. to Present at the virtual Fall Investor Summit on November 16th-18th

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Khiron Life Sciences Corp. (TSXV:KHRN)(OTCQX:KHRNF) will present at the virtual Fall Investor Summit from November 16-18, 2020. This event features 75 companies and attracts over 300 investors. Khiron is a leading cannabis company in Colombia, licensed for cultivation, production, and distribution of medical cannabis, with operations extending to Europe and North America. The company emphasizes patient-oriented approaches and holds a significant market position with products like its CBD skincare brand, Kuida™, available in multiple regions.

Positive
  • None.
Negative
  • None.

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Khiron Life Sciences Corp. ((TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt:A2JMZC)), a vertically integrated cannabis leader with core operations in Latin America and Europe, will be presenting at this year's virtual Fall Investor Summit on November 16th-18th.

The Fall Investor Summit will take place virtually, featuring 75 companies and over 300 institutional and retail investors.

About Khiron Life Sciences Corp.

Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. Khiron is the leading cannabis company in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Peru and has a presence in Mexico, Uruguay, UK, Spain and also in Germany, where it is positioned to begin sales of medical cannabis.

Leveraging its first-mover advantage and patient-oriented approach, Khiron combines global scientific expertise, product innovation, agricultural infrastructure, wholly-owned medical clinics, and online doctor education programs to drive prescription and brand loyalty to address priority medical conditions. Its Wellbeing unit launched the first branded CBD skincare brand in Colombia, with Kuida™ now marketed in multiple jurisdictions in Latin America, the US and UK. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

Visit Khiron online at investors.khiron.ca and on Instagram @khironlife.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company: please contact Brittney Blocker (brittney@investorsummitgroup.com)

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

News Compliments of ACCESSWIRE

FOR MORE INFORMATION

Please visit: www.investorsummitgroup.com

Or, contact Brittney Blocker at brittney@investorsummitgroup.com

SOURCE: Khiron Life Sciences Corp.



View source version on accesswire.com:
https://www.accesswire.com/615962/Khiron-Life-Sciences-Corp-to-Present-at-the-virtual-Fall-Investor-Summit-on-November-16th-18th

FAQ

When is Khiron Life Sciences Corp. presenting at the Fall Investor Summit?

Khiron Life Sciences Corp. will present at the Fall Investor Summit from November 16-18, 2020.

What is the stock symbol for Khiron Life Sciences Corp.?

The stock symbol for Khiron Life Sciences Corp. is KHRNF.

Where does Khiron Life Sciences operate?

Khiron Life Sciences operates primarily in Latin America, with additional activities in Europe and North America.

What products does Khiron Life Sciences offer?

Khiron Life Sciences offers medical cannabis products, including the Kuida™ CBD skincare brand.

How is Khiron Life Sciences positioned in the cannabis market?

Khiron is the leading cannabis company in Colombia and the first licensed for the cultivation, production, and sales of medical cannabis.

KHIRON LIFE SCIENCES CORP

OTC:KHRNF

KHRNF Rankings

KHRNF Latest News

KHRNF Stock Data

6.23M
228.14M
0.22%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver